Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

90
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
90
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

89
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
89
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

106
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
106
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

211
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
211
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

66
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broncholithiasis: Diagnostic and Therapeutic Insights From a Contemporary Case Series of Five Patients.

Cureus·2026
Same author

Corrigendum to 'Pulmonary alveolar proteinosis postlung transplantation: A causation conundrum' [JHLT Open 1 (2023) 100002].

JHLT open·2025
Same author

Pulmonary alveolar proteinosis postlung transplantation: A causation conundrum.

JHLT open·2025
Same author

A top-down spatial scenario approach for identifying the locations of rainwater harvesting sites in an urban region.

Environmental science and pollution research international·2024
Same author

Transforming Medicine with Nanobiotechnology: Nanocarriers and Their Biomedical Applications.

Pharmaceutics·2024
Same author

The physiological role of Acinetobacter baumannii DacC is exerted through influencing cell shape, biofilm formation, the fitness of survival, and manifesting DD-carboxypeptidase and beta-lactamase dual-enzyme activities.

FEMS microbiology letters·2024

Related Experiment Video

Updated: Nov 6, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.7K

Anticoagulation in ECMO patients: an overview.

Gaurav Kumar1, Ashish Maskey2

  • 1Department of Pulmonary Critical Care and Sleep Medicine, University of Kentucky, 740 S. Limestone, Second Floor, Wing C, Room 211, Lexington, KY 40536 USA.

Indian Journal of Thoracic and Cardiovascular Surgery
|May 10, 2021
PubMed
Summary
This summary is machine-generated.

Extracorporeal membrane oxygenation (ECMO) requires anticoagulation due to a pro-thrombotic state. Managing hemostasis during ECMO remains a significant clinical challenge for healthcare providers.

Keywords:
AnticoagulationExtracorporeal life supportExtracorporeal membrane oxygenation

More Related Videos

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.0K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

547

Related Experiment Videos

Last Updated: Nov 6, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.7K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.0K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

547

Area of Science:

  • Cardiology
  • Cardiorespiratory Support
  • Biomedical Engineering

Background:

  • Extracorporeal membrane oxygenation (ECMO) is an advanced life support technique for severe cardiorespiratory failure.
  • ECMO involves external circulation of blood, exposing it to artificial surfaces.
  • This artificial surface contact induces a pro-thrombotic state, necessitating anticoagulation.

Purpose of the Study:

  • To highlight the challenges in managing hemostasis in patients undergoing ECMO.
  • To underscore the need for effective anticoagulation strategies in ECMO therapy.

Main Methods:

  • Review of current practices in ECMO anticoagulation.
  • Discussion of the physiological implications of ECMO on hemostasis.
  • Analysis of the role of unfractionated heparin in ECMO.

Main Results:

  • Unfractionated heparin is the standard anticoagulation method for ECMO.
  • Close monitoring of anticoagulation is essential during ECMO therapy.
  • Despite anticoagulation, hemostasis management remains complex.

Conclusions:

  • Hemostasis management is a critical and ongoing challenge in ECMO.
  • Further research and improved strategies are needed for safer ECMO procedures.